Cargando…

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease

INTRODUCTION: As the role of biomarkers is increasing in Alzheimer's disease (AD) clinical trials, it is critical to use a comprehensive temporal biomarker profile that reflects both baseline and longitudinal assessments to establish a more precise association between the change in biomarkers a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guoqiao, Xiong, Chengjie, McDade, Eric M., Hassenstab, Jason, Aschenbrenner, Andrew J., Fagan, Anne M., Benzinger, Tammie L.S., Gordon, Brian A., Morris, John C., Li, Yan, Bateman, Randall J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288312/ https://www.ncbi.nlm.nih.gov/pubmed/30569014 http://dx.doi.org/10.1016/j.trci.2018.10.009

Ejemplares similares

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2019)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Evaluation of dose‐dependent treatment effects after mid‐trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2022)

Data-driven models of dominantly-inherited Alzheimer’s disease progression
por: Oxtoby, Neil P, et al.
Publicado: (2018)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer’s disease
por: Llibre-Guerra, Jorge J, et al.
Publicado: (2023)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease
por: Hassenstab, Jason, et al.
Publicado: (2021)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease
por: Rahmani, Farzaneh, et al.
Publicado: (2023)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2021)

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
por: Morenas-Rodríguez, Estrella, et al.
Publicado: (2022)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease
por: Lee, Seonjoo, et al.
Publicado: (2018)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
por: Joseph‐Mathurin, Nelly, et al.
Publicado: (2022)

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study
por: O’Connor, Antoinette, et al.
Publicado: (2023)

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study
por: Gordon, Brian A., et al.
Publicado: (2018)

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
por: Müller, Stephan, et al.
Publicado: (2017)

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease
por: Tu, Jiaxin Cindy, et al.
Publicado: (2023)

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
por: Wang, Qing, et al.
Publicado: (2022)

Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?
por: Kennedy, Richard E., et al.
Publicado: (2015)

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
por: Rios‐Romenets, Silvia, et al.
Publicado: (2020)

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
por: Millar, Peter R, et al.
Publicado: (2023)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
por: Araque Caballero, Miguel Ángel, et al.
Publicado: (2018)

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

Discovery and validation of dominantly inherited Alzheimer’s disease mutations in populations from Latin America
por: Takada, Leonel Tadao, et al.
Publicado: (2022)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

Deep residual inception encoder‐decoder network for amyloid PET harmonization
por: Shah, Jay, et al.
Publicado: (2022)

Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2022)

Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network
por: Warren‐Gash, Charlotte, et al.
Publicado: (2022)

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
por: Bollinger, Rebecca M, et al.
Publicado: (2021)

The informed road map to prevention of Alzheimer Disease: A call to arms
por: McDade, Eric, et al.
Publicado: (2021)

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease
por: Salvadó, Gemma, et al.
Publicado: (2023)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
por: Moulder, Krista L, et al.
Publicado: (2013)

Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
por: McKay, Nicole S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rsn3p780e7lnui4cq7lputu4mh